title: Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease.
abstract: The nontuberculous mycobacteria (NTM), defined as any mycobacterial pathogen other than Mycobacterium tuberculosis or Mycobacterium leprae, are a diverse group of pathogens that collectively cause a substantive but often unappreciated worldwide burden of illness. Although NTMs may cause illness similar to M. tuberculosis, these pathogens generally do not respond to classic tuberculosis (TB) drug regimens, resulting in misdiagnosis and poor treatment, particularly in resource-poor settings. Although a few high-quality epidemiologic surveys have been made on the topic, existing evidence suggests that NTM-associated disease is much more common than previously thought: more common than TB in the industrialized world and likely increasing in prevalence globally. Despite this evidence, these organisms remain markedly understudied, and few international grants support basic science and clinical research. Here we suggest that the considerable efforts in developing new treatments and diagnostics for TB can be harnessed in the fight against NTM-associated illnesses.
authors.forename: Ravikiran M
authors.initials: RM
authors.lastname: Raju
authors.forename: Sagar M
authors.initials: SM
authors.lastname: Raju
authors.forename: Yanlin
authors.initials: Y
authors.lastname: Zhao
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Rubin
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D035843:Biomedical Research; D006801:Humans; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000178:diet therapy*; D009169:Mycobacterium tuberculosis; D009170:Nontuberculous Mycobacteria; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents
keywords: M. abscessus; M. avium; M. ulcerans; Mtb; Mycobacterium leprae; Mycobacterium tuberculosis; NTM disease; antimycobacterial; antitubercular; bacteria; bedaquiline; clarithromycin; delamanid; macrolides; nontuberculous mycobacteria; oxazolidinones; respiratory infections; tuberculosis